↓ Skip to main content

Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms…

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
12 X users

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
Published in
Journal for Immunotherapy of Cancer, November 2015
DOI 10.1186/2051-1426-3-s2-o8
Authors

John Powderly, Gregory Cote, Keith Flaherty, Russell Z Szmulewitz, Antoni Ribas, Jeffrey Weber, Deryk Loo, Jan Baughman, Francine Chen, Paul Moore, Ezio Bonvini, James Vasselli, Jon Wigginton, Roger Cohen, Howard Burris, Bartosz Chmielowski

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 18%
Researcher 8 16%
Other 5 10%
Student > Bachelor 4 8%
Student > Doctoral Student 3 6%
Other 5 10%
Unknown 17 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 7 14%
Biochemistry, Genetics and Molecular Biology 7 14%
Agricultural and Biological Sciences 7 14%
Medicine and Dentistry 6 12%
Immunology and Microbiology 3 6%
Other 2 4%
Unknown 19 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 December 2021.
All research outputs
#2,283,233
of 25,734,859 outputs
Outputs from Journal for Immunotherapy of Cancer
#611
of 3,498 outputs
Outputs of similar age
#31,961
of 297,615 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 97 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,498 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,615 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.